C-1101

Asset

Potential first-in-class disease-modifying therapeutic for chronic sciatica

Stage: Phase 1
Modality: Other
Target: Not known; 1
Indication: 0
Trials: 1
Developer

Indications

1

Chronic painful lumbosacral radiculopathy
Phase 1, prnewswire.com, 5 Oct 2026

In the full profile

Owner and partners1

Every asset’s record: target, stage, trials and the evidence behind it.